Business Insider
US · 1 hrs ago
✦ 72◉ Centre
The $950 cancer blood test is here: 5 things to consider before ordering yours
72Quality
0Ratings
0Comments
AI Analysis
Quality 72/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Grail's $950 multi-cancer blood test is available through telemedicine but lacks FDA approval. The article examines considerations for consumers about a test that can screen for dozens of cancer types, with varying effectiveness depending on cancer type.
The $950 cancer blood test is here: 5 things to consider before ordering yours
Grail's $950 blood test isn't FDA-approved yet, but you can get one easily via telemedicine.
Zoë Meyers for BI
Multi-cancer blood tests are generally seen as the future of cancer detection.
The promise is that with a few vials of blood, you could test for dozens of cancers at once.
For now, the tests seem far better at picking up some cancers than others.
Is a $950 test that searches for upwards of 50 types of cancer in your bloodstream worth it? That depends on who you ask.
Grail, the Silicon
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!